GigaGen's
recombinant polyclonal IgG solves the significant challenges of these current plasma - based products.
GigaGen is advancing a pipeline of first - in - class biotherapeutics, including novel oncology antibody drug combinations and the world's first
recombinant polyclonal hyperimmune gammaglobulin.
Not exact matches
Bethyl's portfolio consists of
polyclonal and monoclonal antibodies, including new
recombinant rabbit monoclonal antibodies.
Including
recombinant proteins, stable reporter cell lines,
polyclonal antibodies and ELISA assay kits
Among other applications, its innovative technological platform enables identifying and analyzing the genetic diversity of B cells to convert them into
polyclonal recombinant antibodies (biotherapeutics) that improve outcomes for patients with severe diseases.